A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)

PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

June 29, 2023

Study Completion Date

June 29, 2023

Conditions
Chronic Cluster Headache
Interventions
DRUG

Eptinezumab

Eptinezumab will be administered per schedule specified in the arm description.

Trial Locations (31)

2600

Rigshospitalet Glostrup, Glostrup Municipality

8800

Hospitalsenhed Midt og Regionshospitalet Viborg, Viborg

10117

Charité Campus Mitte, Berlin

10126

Ospedale Molinette - Clinica Neurologica II - Centro Cefalee, Turin

13005

Hôpital de la Timone, Marseille

14226

Dent Neurologic Institute - Amherst, Amherst

19107

Thomas Jefferson University Hospital - Center City Campus, Philadelphia

20100

Terveystalo Turku Pulssi, Turku

20133

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Fondazione Istituto Neurologico Car..., Milan

27100

Fondazione Mondino - Istituto Neurologico Nazionale a Carattere Scientifico IRCCS, Pavia

39008

Hospital Universitario Marques de Valdecilla, Santander

40123

IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna

41013

Hospital Universitario Virgen del Rocío, Seville

42055

Centre Hospitalier Universitaire de Saint-Étienne, Saint-Priest-en-Jarez

44195

Cleveland Clinic - Neurological Institute, Cleveland

46010

Hospital Clínico Universitario de Valencia, Valencia

47010

Hospital Clínico Universitario de Valladolid, Valladolid

59037

Hôpital Roger Salengro, Lille

65929

Kopfschmerzzentrum Frankfurt, Frankfurt am Main

69677

Hôpital Pierre Wertheimer, Bron

75010

Hôpital Lariboisière, Paris

06905

New England Institute for Neurology and Headache, Stamford

48104-5131

Michigan Headache and Neurological Institute, Ann Arbor

00180

Terveystalo Ruoholahti, Helsinki

91179 - 06003

Hôpital Cimiez, Nice

00163

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - San Raffaele Pisana, Rome

6532 SZ

Canisius-Wilhelmina Ziekenhuis, Nijmegen

1081 GN

Brain Research Center - Amsterdam, Amsterdam

08035

Hospital Universitari Vall d'Hebron, Barcelona

L9 7LJ

The Walton Centre NHS Foundation Trust, Liverpool

SE5 9RS

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT05064397 - A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) | Biotech Hunter | Biotech Hunter